Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 4, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Pratt Home Builders To Host Ironman Training Event

Pratt Home Builders will host 4 Ironman training events for the twelve athletes who will be participating as Emily’s Power for a Cure Team in the 2015 Chattanooga Ironman competition scheduled for September 27. The first event will be Sunday, March 8 starting at 2:30 p.m.  Andy Sweet, a trainer at HUB Endurance, has set this challenge as a 3 mile pace training event. Each ... (click for more)

CHI Memorial To Host "Cancer Care, Today" Conference

CHI Memorial will host “Cancer Care, Today” to help educate the community about treatment advances, forward-thinking nutrition and emotional support, and access to specialists at CHI Memorial’s Rees Skillern Cancer Institute. Question and answer sessions will be open after each presentation. A light breakfast is provided. “Cancer Care, Today” is free for all attendees. The ... (click for more)

Thornhill Charged In February 2013 Burning Death Of Lucius Moss On Wilcox Boulevard

Ellis Bell Thornhill, 38, has been indicted by the Hamilton County Grand Jury on first-degree murder charges in the Feb. 7, 2013, death of 37-year-old Lucius Moss. His body was found inside a burned duplex at 1802 Wilcox Blvd. Thornhill is also facing charges of especially aggravated kidnapping, aggravated arson, aggravated assault and abuse of a corpse. The Chattanooga Fire ... (click for more)

Woman Stabbed By Husband In Dalton Dies From Her Wounds

A woman who Dalton Police say was stabbed Thursday by her husband has died of her injuries.   Glenda Dyer had been transported to Hamilton Medical Center. She initially was listed in stable condition.   The incident happened at the couple's home at 1603 Elaine Way.   Police said a murder charge will be added to the counts already facing ... (click for more)

Net Neutrality: The Beginning Of The End Or Just A New Beginning?

“The Internet is simply too important to be left without rules and without a referee on the field,” says Tom Wheeler, chairman of the Federal Communications Commission, “Today’s order is more powerful and more expansive than any previously suggested.”  The FCC’s vote for so-called Net Neutrality purports to allow the agency to regulate the Internet as a public utility.  ... (click for more)

Roy Exum: Cameras Or Subterfuge?

State Rep. Andy Holt (R-Dresden) is an easy-to-like member of the Tennessee Legislature and the fact he is teaming with state senator Todd Gardenhire (R-Chattanooga) to rid the state of its loathsome traffic cameras is indeed a wonderful thing. The legislative action is long overdue, with the biggest winners being the out-of-state camera companies. That alone is just about all you ... (click for more)